BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28969269)

  • 1. Role of Cathepsin B as a Marker of Malignant Transformation in Oral Lichen Planus: An Immunohistochemical Study.
    Satelur KP; Bopaiah S; Bavle RM; Ramachandra P
    J Clin Diagn Res; 2017 Aug; 11(8):ZC29-ZC32. PubMed ID: 28969269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Cathepsin L in oral lichen planus.
    Kitkhajornkiat A; Rungsiyanont S; Talungchit S; Jirawechwongsakul P; Taebunpakul P
    J Oral Biol Craniofac Res; 2020; 10(3):281-286. PubMed ID: 32612918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
    Jaafari-Ashkavandi Z; Aslani E
    Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Cathepsin B and Cystatin A in Oral Lichen Planus.
    Bangsuwan P; Hirunwidchayarat W; Jirawechwongsakul P; Talungchit S; Taebunpakul P
    J Int Soc Prev Community Dent; 2021; 11(5):566-573. PubMed ID: 34760802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of P21 Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma by Immunohistochemical Technique.
    Baghaei F; Shojaei S; Afshar-Moghaddam N; Zargaran M; Rastin V; Nasr M; Moghimbeigi A
    J Dent (Shiraz); 2015 Sep; 16(3):156-61. PubMed ID: 26331143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
    Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.
    Agha-Hosseini F; Sheykhbahaei N; SadrZadeh-Afshar MS
    J Contemp Dent Pract; 2016 Aug; 17(8):692-701. PubMed ID: 27659090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of BIRC6 Expression in Oral Squamous Cell Carcinoma, Epithelial Dysplasia, Lichen Planus with and without Dysplasia, and Hyperkeratosis.
    Eskandari F; Razavian A; Zare R; Ejlali S; Razmahang A; Zanjani M; Aghili SS; Mahdiyar MA; Mofidi H; Abbasi K; Badkoobeh A; Shamloo N; Hakim LK; Hussain A; Tebyaniyan H
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
    Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of cytokeratin-19 in the oral lichen planus and related oral squamous cell carcinoma.
    Bombeccari GP; Giannì AB; Spadari F
    Ann Stomatol (Roma); 2017; 8(3):104-109. PubMed ID: 29682222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin K expression is increased in oral lichen planus.
    Siponen M; Bitu CC; Al-Samadi A; Nieminen P; Salo T
    J Oral Pathol Med; 2016 Nov; 45(10):758-765. PubMed ID: 27152719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in oral lichen planus: Role in malignant transformation.
    Suganya G; Bavle RM; Paremala K; Makarla S; Sudhakar M; Reshma V
    J Oral Maxillofac Pathol; 2016; 20(2):234-8. PubMed ID: 27601815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of p16 protein in oral squamous cell carcinoma and lichen planus.
    Salehinejad J; Sharifi N; Amirchaghmaghi M; Ghazi N; Shakeri MT; Ghazi A
    Ann Diagn Pathol; 2014 Aug; 18(4):210-3. PubMed ID: 24850170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-1α and glucose transporter 1 in the malignant transformation of oral lichen planus.
    Wang XX; Sun HY; Yang QZ; Guo B; Sai Y; Zhang J
    Int J Clin Exp Pathol; 2017; 10(8):8369-8376. PubMed ID: 31966688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Paxillin Expression in Epithelial Dysplasia, Oral Squamous Cell Carcinoma, Lichen Planus with and without Dysplasia, and Hyperkeratosis: A Retrospective Cross-Sectional Study.
    Aghili SS; Zare R; Jahangirnia A
    Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.
    Shailaja G; Kumar JV; Baghirath PV; Kumar U; Ashalata G; Krishna AB
    Dent Res J (Isfahan); 2015; 12(3):235-42. PubMed ID: 26005463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus.
    Oliveira Alves M; Balducci I; Rodarte Carvalho Y; Cabral L; Nunes F; Almeida J
    Oral Dis; 2013 Nov; 19(8):775-80. PubMed ID: 23350884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.